77 related articles for article (PubMed ID: 19488079)
1. Is there an inherent limit to acute migraine treatment efficacy?
Bigal ME; Ho TW
J Headache Pain; 2009 Dec; 10(6):393-4. PubMed ID: 19820895
[No Abstract] [Full Text] [Related]
2. ELEVATEd hope for patients after migraine treatment failure.
Xu X; Dong L; Zhou J
Lancet Neurol; 2024 Apr; 23(4):328-330. PubMed ID: 38364830
[No Abstract] [Full Text] [Related]
3. New migraine drugs.
Puledda F; Tassorelli C; Diener HC
Cephalalgia; 2023 Mar; 43(3):3331024221144784. PubMed ID: 36786364
[No Abstract] [Full Text] [Related]
4. Migraine: Telcagepant provides new hope for people with migraine.
Edvinsson L
Nat Rev Neurol; 2009 May; 5(5):240-2. PubMed ID: 19488079
[No Abstract] [Full Text] [Related]
5. CGRP antagonists: hope for a new era in acute migraine treatment.
Schelstraete C; Paemeleire K
Acta Neurol Belg; 2009 Dec; 109(4):252-61. PubMed ID: 20120204
[TBL] [Abstract][Full Text] [Related]
6. ACS chemical neuroscience molecule spotlight on Telcagepant (MK-0974).
Hopkins CR
ACS Chem Neurosci; 2011 Jul; 2(7):334-5. PubMed ID: 22816019
[TBL] [Abstract][Full Text] [Related]
7. Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
Tepper SJ; Stillman MJ
Headache; 2008 Sep; 48(8):1259-68. PubMed ID: 18808506
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
Durham PL; Vause CV
CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
Cui XP; Ye JX; Lin H; Mu JS; Lin M
Pain Pract; 2015 Feb; 15(2):124-31. PubMed ID: 24382126
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis.
Regan CP; Stump GL; Kane SA; Lynch JJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):571-8. PubMed ID: 18997059
[TBL] [Abstract][Full Text] [Related]
12. Central projections of the sensory innervation of the rat middle meningeal artery.
Liu Y; Broman J; Edvinsson L
Brain Res; 2008 May; 1208():103-10. PubMed ID: 18395192
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.
Ho TW; Mannix LK; Fan X; Assaid C; Furtek C; Jones CJ; Lines CR; Rapoport AM;
Neurology; 2008 Apr; 70(16):1304-12. PubMed ID: 17914062
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
